[FOSAVANCE -- alendronate plus vitamin D in a weekly tablet].
D019386:Alendronate / Q000008:administration & dosage*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D018849:Controlled Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy; D016103:Spinal Fractures / Q000517:prevention & control; D013607:Tablets; D013997:Time Factors; D014807:Vitamin D / Q000008:administration & dosage* / Q000097:blood
D050071:Bone Density Conservation Agents; D004338:Drug Combinations; D013607:Tablets; D014807:Vitamin D; D019386:Alendronate